Kieckhefer Group LLC bought a new stake in The Procter & Gamble Company (NYSE:PG – Free Report) in the 4th quarter, HoldingsChannel.com reports. The firm bought 1,400 shares of the company’s stock, valued at approximately $235,000.
Other hedge funds have also recently added to or reduced their stakes in the company. Concurrent Investment Advisors LLC raised its position in Procter & Gamble by 4.5% during the third quarter. Concurrent Investment Advisors LLC now owns 94,109 shares of the company’s stock worth $16,300,000 after acquiring an additional 4,035 shares during the period. Copley Financial Group Inc. purchased a new position in Procter & Gamble in the 3rd quarter valued at about $668,000. Fortem Financial Group LLC purchased a new stake in Procter & Gamble during the 4th quarter worth approximately $569,000. Synovus Financial Corp raised its holdings in shares of Procter & Gamble by 3.4% during the third quarter. Synovus Financial Corp now owns 185,134 shares of the company’s stock valued at $32,065,000 after acquiring an additional 6,077 shares during the last quarter. Finally, Nordea Investment Management AB lifted its position in shares of Procter & Gamble by 7.5% in the fourth quarter. Nordea Investment Management AB now owns 2,898,569 shares of the company’s stock valued at $484,583,000 after acquiring an additional 201,695 shares in the last quarter. 65.77% of the stock is owned by hedge funds and other institutional investors.
Procter & Gamble Stock Up 0.1 %
PG stock traded up $0.09 during midday trading on Monday, hitting $158.65. The company’s stock had a trading volume of 2,137,947 shares, compared to its average volume of 6,157,047. The Procter & Gamble Company has a 52-week low of $146.28 and a 52-week high of $180.43. The firm has a 50-day simple moving average of $169.64 and a 200-day simple moving average of $169.61. The company has a quick ratio of 0.55, a current ratio of 0.75 and a debt-to-equity ratio of 0.50. The firm has a market capitalization of $373.63 billion, a P/E ratio of 27.35, a PEG ratio of 3.70 and a beta of 0.45.
Analyst Upgrades and Downgrades
Several equities analysts have recently weighed in on the stock. Evercore ISI raised their price target on shares of Procter & Gamble from $180.00 to $183.00 and gave the stock an “outperform” rating in a research note on Monday, October 21st. Morgan Stanley upped their price target on Procter & Gamble from $174.00 to $191.00 and gave the company an “overweight” rating in a research report on Monday, October 21st. Barclays downgraded Procter & Gamble from an “overweight” rating to an “equal weight” rating and set a $163.00 price objective on the stock. in a research report on Monday, September 30th. Royal Bank of Canada restated a “sector perform” rating and issued a $164.00 target price on shares of Procter & Gamble in a report on Monday, October 21st. Finally, Piper Sandler initiated coverage on Procter & Gamble in a report on Tuesday, September 24th. They set a “neutral” rating and a $174.00 price target on the stock. Eight research analysts have rated the stock with a hold rating, fourteen have assigned a buy rating and two have issued a strong buy rating to the company’s stock. According to data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average price target of $179.75.
Check Out Our Latest Research Report on Procter & Gamble
Insider Buying and Selling
In other news, CEO R. Alexandra Keith sold 1,992 shares of the company’s stock in a transaction on Tuesday, October 22nd. The shares were sold at an average price of $170.00, for a total value of $338,640.00. Following the completion of the transaction, the chief executive officer now owns 13,783 shares in the company, valued at approximately $2,343,110. This represents a 12.63 % decrease in their position. The sale was disclosed in a filing with the SEC, which is accessible through this link. Also, CEO Gary A. Coombe sold 47,847 shares of the business’s stock in a transaction on Wednesday, November 27th. The shares were sold at an average price of $179.84, for a total transaction of $8,604,804.48. Following the completion of the sale, the chief executive officer now directly owns 39,977 shares of the company’s stock, valued at approximately $7,189,463.68. This trade represents a 54.48 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 75,439 shares of company stock worth $13,317,460 over the last 90 days. 0.18% of the stock is owned by insiders.
About Procter & Gamble
Procter & Gamble Co engages in the provision of branded consumer packaged goods. It operates through the following segments: Beauty, Grooming, Health Care, Fabric and Home Care, and Baby, Feminine and Family Care. The Beauty segment offers hair, skin, and personal care. The Grooming segment consists of shave care like female and male blades and razors, pre and post shave products, and appliances.
Featured Articles
- Five stocks we like better than Procter & Gamble
- How to Know Which Cryptocurrency to Buy: A Guide for Investors
- Rigetti Computing, Inc.: Buy, Sell, or Hold for 2025
- How to Use the MarketBeat Excel Dividend Calculator
- Delta Can Fly to New Highs in 2025; Here’s Why
- How to Choose Top Rated Stocks
- Snowflake Stock: Bullish Upgrades Demand Investors’ Attention
Want to see what other hedge funds are holding PG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Procter & Gamble Company (NYSE:PG – Free Report).
Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.